Skip to main content
OpenTrials

Clinical trial condition

Amyotrophic Lateral Sclerosis

Explore clinical trials studying Amyotrophic Lateral Sclerosis. Study availability and eligibility vary by location and protocol.

707 public trials 173 recruiting studies
Refine in advanced search Browse all conditions

Amyotrophic Lateral Sclerosis trial results

Completed

EH301 for the Treatment of ALS

NCT03489200

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • Universidad Católica de Valencia San Vicente Màrtir Valencia, Spain
View Trial Details
Completed

Trial of Safety and Efficacy of Rasagiline in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT01232738

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • Phoenix Neurological Institute Phoenix, Arizona, United States
  • California Pacific Medical Center San Francisco, California, United States
  • University of Iowa Iowa City, Iowa, United States
  • University Of Kansas Medical Center Kansas City, Kansas, United States
View Trial Details
Completed

Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation

NCT02794857

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Inflammation, +11 more
Locations
  • St. Joseph's Hospital and Medical Center - Barrow Neurology Clinics Phoenix, Arizona, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California, Irvine, Department of Neurology Orange, California, United States
View all 22 locations
View Trial Details
Completed

Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis

NCT01753076

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site Grand Rapids, Michigan, United States
  • GSK Investigational Site Syracuse, New York, United States
  • GSK Investigational Site Columbus, Ohio, United States
View all 35 locations
View Trial Details

Related conditions